id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-P-2952-0006,FDA,FDA-2024-P-2952,"Determination That LUNELLE (Estradiol Cypionate and Medroxyprogesterone Acetate) Injectable, 5 Milligrams/0.5 Milliliter and 25 Milligrams/0.5 Milliliter, Was Not Withdrawn From Sale for Reasons of
Safety or Effectiveness",Notice,Determinations,2025-12-12T05:00:00Z,2025,12,2025-12-12T05:00:00Z,,2025-12-12T22:12:49Z,2025-22680,0,0,09000064b90cb51b
FDA-2024-P-2952-0007,FDA,FDA-2024-P-2952,Response Letter,Other,Letter(s),2025-12-12T05:00:00Z,2025,12,2025-12-12T05:00:00Z,,2026-01-09T20:18:51Z,,0,0,09000064b90cb518
FDA-2024-P-2952-0005,FDA,FDA-2024-P-2952,Interim Response Letter from FDA CDER to Sarah A. Norring,Other,Response(s),2024-12-16T05:00:00Z,2024,12,2024-12-16T05:00:00Z,,2024-12-16T21:22:03Z,,0,0,0900006486876945
FDA-2024-P-2952-0003,FDA,FDA-2024-P-2952,Attachment 1 - FedReg Lunelle,Supporting & Related Material,Background Material,2024-06-21T04:00:00Z,2024,6,,,2024-06-21T19:07:03Z,,0,0,09000064865c27ff
FDA-2024-P-2952-0002,FDA,FDA-2024-P-2952,Acknowledgment Letter from FDA DMS to Sarah A. Norring,Other,Acknowledgement Letter/Receipt,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2024-06-21T19:06:55Z,,0,0,09000064865c2dfc
FDA-2024-P-2952-0004,FDA,FDA-2024-P-2952,Attachment 2 - Lunelle Voluntary Recall,Supporting & Related Material,Background Material,2024-06-21T04:00:00Z,2024,6,,,2024-06-21T19:07:07Z,,0,0,09000064865c2804
FDA-2024-P-2952-0001,FDA,FDA-2024-P-2952,Citizen Petition from Sarah A. Norring,Other,Citizen Petition,2024-06-21T04:00:00Z,2024,6,2024-06-21T04:00:00Z,,2025-12-12T22:04:11Z,,0,0,09000064865c2dfb